Respironics Raises UK Profile: Distributor Purchase Yields Drug Delivery Tech
Respironics' planned integration of UK distributor Profile Therapeutics includes access to Profile's Prodose inhaled aerosol drug delivery technology
More from Archive
More from Medtech Insight
• By
“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.
• By
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
• By
Joshi joins the parent company of Citeline, home of Medtech Insight, to focus on AI, business harmonization and long-term growth.